To further characterize the association between these variants and the predisposition to thyroid cancer, they genotyped CHEK2 in 468 unselected patients with PTC, detecting causative variants in 73 of the 468 (15.6%) unselected PTC patients [78]. Here, CHEK2 is linked to thyroid gland carcinoma.